Imperial College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes

drug resistance PhD Projects, Programs & Scholarships

We have 100 drug resistance PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 100 drug resistance PhD Projects, Programs & Scholarships

PhD saved successfully

EASTBIO Molecular and regulatory insights into getting out of mitosis

  Research Group: Institute of Cell Biology
The fidelity of chromosome segregation is essential to ensure genome stability. Failure to exit mitosis and complete cell division results in tetraploidy and extra centrosomes which is a path to tumour development and drug resistance. Read more

PhD in Chemistry: Medicinal Chemistry of Nucleotide Analogues

Nucleoside analogues (NAs) are an important class of antiviral and anticancer agents commonly used in the therapy of many different viral infections and cancer conditions. Read more

Multilevel selection on transposition rates in cancer

Cancer is an evolutionary process. Cells in a tumour vary due to mutation, and so over many generations they adapt in response to both intrinsic selective pressures (such as anoxia) and extrinsic selective pressures (such as chemotherapy). Read more

The development of Rab27 inhibitors for treatment of cancer cell invasion and proliferation

Rab27 small GTPases regulate movement and exocytosis of secretory granules in cell types including; melanocytes (melanosomes), T lymphocytes (lytic granules), granulocytes (azurophilic granules) and mast cells [1]. Read more

White Rose BBSRC DTP studentship: Probing a novel allosteric binding site in Mycobacterium DNA gyrase to tackle TB and antimicrobial resistance

Human pathogenic bacteria, e.g. Mycobacterium tuberculosis (TB), show increasing resistance to current antibiotics. Antimicrobial resistance (AMR) is probably the biggest current threat to human health; it is estimated that 10 million people per year could die because of AMR by 2050. Read more

Understanding Multiple Antibiotic Resistance in Gram-negative Bacteria

  Research Group: BBSRC MIBTP
Antibiotics have transformed medical practice, increased life expectancy and, together with vaccination, led to the near eradication of many bacterial diseases. Read more

Brk and mTOR signalling: implications for Taxol resistance

One of the major causes of death amongst breast cancer patients is due to the development of distal metastases and the acquisition of resistance to chemotherapeutic agents. Read more

Filtering Results